Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Topoisomerase inhibition refers to the process of blocking the activity of topoisomerases, which are essential enzymes that regulate DNA topology during critical cellular processes such as replication, transcription, and recombination. There are two main types of topoisomerases targeted by inhibitors: Topoisomerase I (Top1) and Topoisomerase II (Top2). Inhibitors block the action of topoisomerases, leading to accumulation of DNA damage. This results in persistent DNA breaks that can trigger cell cycle arrest or apoptosis. Many topoisomerase inhibitors are used as chemotherapeutic agents due to their ability to induce lethal DNA damage selectively in rapidly dividing tumor cells.
Inhibitors block the action of topoisomerases, leading to accumulation of DNA damage by stabilizing the enzyme-DNA cleavage complex at single-stranded or double-stranded nicks, preventing re-ligation or strand passage. This results in persistent DNA breaks that can trigger cell cycle arrest or apoptosis.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Topoisomerase Inhibition (Topo Inhibition).